HCV-IN-30 is a potent small molecule inhibitor targeting the Hepatitis C Virus NS5A protein, demonstrating inhibitory concentrations (IC50) of 901 nM and 102 nM against genotype 1a and 1b replicons, respectively. This compound is a valuable research tool for studying HCV replication mechanisms and antiviral strategies in vitro.